Jasmine-compound and standard-therapy combination show promise as BPH treatment

21 Feb 2017


A jasmine-derived organic compound called methyl jasmonate (MeJA) could be used in conjunction with standard therapies to treat men with enlarged prostates, according to a study published in Phytotherapy Research.

BPH News


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story